Eurobio Scientific SA
PAR:ALERS
Eurobio Scientific SA
PAR:ALERS
Price:
25.65
EUR
7.55%
Market Closed
Market Cap:
256.6m
EUR
Balance Sheet
Balance Sheet Decomposition
Eurobio Scientific SA
Eurobio Scientific SA
| Current Assets | 146.7m |
| Cash & Short-Term Investments | 86.6m |
| Receivables | 35m |
| Other Current Assets | 25.1m |
| Non-Current Assets | 167.1m |
| PP&E | 11.6m |
| Intangibles | 150.4m |
| Other Non-Current Assets | 5.1m |
Balance Sheet
Eurobio Scientific SA
Eurobio Scientific SA
Currency: EUR
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
14
|
12
|
8
|
12
|
11
|
8
|
66
|
102
|
86
|
89
|
|
| Cash Equivalents |
14
|
12
|
8
|
12
|
11
|
8
|
66
|
102
|
86
|
89
|
|
| Total Receivables |
7
|
7
|
7
|
11
|
11
|
22
|
55
|
54
|
40
|
32
|
|
| Accounts Receivables |
5
|
4
|
5
|
8
|
8
|
17
|
52
|
44
|
33
|
27
|
|
| Other Receivables |
3
|
3
|
2
|
3
|
3
|
5
|
3
|
9
|
7
|
5
|
|
| Inventory |
2
|
2
|
2
|
7
|
9
|
9
|
13
|
16
|
22
|
21
|
|
| Other Current Assets |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
2
|
|
| Total Current Assets |
24
|
21
|
19
|
31
|
32
|
40
|
135
|
174
|
149
|
144
|
|
| PP&E Net |
1
|
1
|
1
|
4
|
5
|
8
|
10
|
10
|
13
|
12
|
|
| PP&E Gross |
1
|
1
|
1
|
4
|
5
|
8
|
10
|
10
|
13
|
12
|
|
| Accumulated Depreciation |
7
|
8
|
6
|
7
|
9
|
10
|
10
|
13
|
16
|
22
|
|
| Intangible Assets |
12
|
11
|
9
|
12
|
10
|
8
|
6
|
4
|
39
|
37
|
|
| Goodwill |
2
|
2
|
2
|
24
|
22
|
23
|
21
|
18
|
116
|
116
|
|
| Other Long-Term Assets |
1
|
0
|
1
|
1
|
1
|
3
|
1
|
4
|
14
|
7
|
|
| Other Assets |
2
|
2
|
2
|
24
|
22
|
23
|
21
|
18
|
116
|
116
|
|
| Total Assets |
40
N/A
|
36
-12%
|
32
-11%
|
72
+124%
|
70
-2%
|
81
+16%
|
172
+113%
|
210
+22%
|
331
+58%
|
316
-4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
5
|
5
|
5
|
9
|
7
|
9
|
7
|
7
|
13
|
13
|
|
| Accrued Liabilities |
3
|
2
|
1
|
3
|
3
|
3
|
5
|
7
|
10
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
4
|
7
|
8
|
8
|
15
|
4
|
15
|
15
|
|
| Other Current Liabilities |
1
|
3
|
6
|
6
|
6
|
11
|
20
|
17
|
19
|
19
|
|
| Total Current Liabilities |
10
|
10
|
16
|
25
|
24
|
32
|
48
|
36
|
57
|
53
|
|
| Long-Term Debt |
8
|
6
|
2
|
14
|
15
|
11
|
15
|
11
|
99
|
86
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
3
|
2
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
2
|
|
| Total Liabilities |
21
N/A
|
19
-10%
|
21
+10%
|
41
+100%
|
42
+1%
|
46
+10%
|
65
+42%
|
49
-24%
|
158
+221%
|
141
-11%
|
|
| Equity | |||||||||||
| Common Stock |
1
|
1
|
1
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
|
| Retained Earnings |
101
|
107
|
114
|
124
|
128
|
125
|
63
|
117
|
129
|
138
|
|
| Additional Paid In Capital |
120
|
123
|
125
|
152
|
153
|
156
|
40
|
40
|
40
|
34
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
20
N/A
|
17
-14%
|
11
-34%
|
30
+168%
|
28
-7%
|
35
+25%
|
107
+204%
|
161
+50%
|
173
+8%
|
175
+1%
|
|
| Total Liabilities & Equity |
40
N/A
|
36
-12%
|
32
-11%
|
72
+124%
|
70
-2%
|
81
+16%
|
172
+113%
|
210
+22%
|
331
+58%
|
316
-4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3
|
4
|
4
|
10
|
10
|
11
|
11
|
11
|
11
|
10
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
